Introductionexpression in the spleen and lowest in skeletal muscle (data not shown). To determine whether individual cell types coexpressed the different splice variants of kazrin, semi-quantitative RT-PCR was performed on cultured cells (Fig. 1C) . Transcripts of all kazrin isoforms were expressed in all three cell types examined, with higher expression of kazrinE in A431 and EJ/28 cells than in primary human keratinocytes.
The predicted domains of kazrinE are illustrated schematically in Fig. 1D . It is possible that three forms of kazrinE, containing the N-terminus of kazrinA, kazrinB or kazrinC, exist; however, thus far only cDNA clones containing the kazrinA N-terminus have been identified in searches of public databases (data not shown). KazrinE and the shorter isoforms share the coiled-coil domain and putative nuclear-localisation signal (NLS; at amino acids 376 and 382 in kazrinA). However, whereas kazrinA, kazrinB and kazrinC share a common C-terminus, the kazrinE C-terminus contains the LHD with the three SAM domains located between amino acids 446 and 511, 524 and 588, and 612 and 679. KazrinE also has a PDZ-binding motif at the extreme C-terminus (amino acids 772-775) (Fig. 1D ). Human kazrinE is highly homologous to the mouse and rat isoforms, having 90% amino acid identity (BLAST alignment) (Altschul et al., 1990 ) (data not shown).
KazrinE interacts with the LAR-type receptor protein tyrosine phosphatase
Liprin 1 was originally identified by its ability to bind LAR, an interaction mediated by the SAM domains (Pulido et al., 1995; Serra-Pages et al., 1995) . LAR is known to accumulate at adherens junctions and desmosomes, via binding to plakoglobin and bcatenin, and to regulate both junction assembly and b-catenin signalling (Kypta et al., 1996; Aicher et al., 1997; Muller et al., 1999) . To probe the potential interaction between kazrinE and LAR, we performed co-immunoprecipitation experiments using total cell lysates from 293T cells co-transfected with N-terminally haemagglutinin (HA)-tagged kazrinE and green fluorescent protein (GFP)-LAR (Fig. 1E ). HA-kazrinE and GFP-LAR could be coimmunoprecipitated from lysates prepared in the presence, but not in the absence, of phosphatase inhibitors (Fig. 1E ), in agreement with previous work showing that liprin phosphorylation regulates binding to LAR (Serra-Pages et al., 2005) .
To examine whether kazrinE can be tyrosine phosphorylated, we transfected A431 cells with HA-tagged kazrinE, serum starved the cells overnight and then treated them for 1 hour with epidermal growth factor (EGF) (Fig. 1F) . Cell lysates were immunoprecipitated with anti-HA and then immunoblotted with anti-phosphotyrosine antibody or, as controls for transfection and loading, respectively, with anti-HA and anti--tubulin (Fig. 1F ). On treatment with EGF, weak tyrosine phosphorylation of kazrinE was detected.
Although the ability of kazrinE to associate with LAR ( Fig. 1E ) is predicted from the existence of the LHD and could potentially be regulated by tyrosine phosphorylation (Fig. 1F ), we were unable to co-immunoprecipitate endogenous LAR and kazrinE in the presence or absence of phosphatase inhibitors (data not shown). Furthermore, when the subcellular distribution of GFP-LAR and HA-kazrinE was compared in transfected primary human keratinocytes, HA-kazrinE and GFP-LAR showed only partial colocalisation (Fig. 1G ). There was some colocalisation of LAR and kazrinE at the cell periphery (Fig. 1G) . However, HA-kazrinE accumulated primarily in perinuclear filaments, whereas GFP-LAR had a more widespread and punctate distribution throughout the cytoplasm (Fig. 1G) . We conclude that, although kazrinE, like liprin- family members, can bind LAR, the majority of kazrinE is not associated with LAR and therefore kazrinE function is unlikely to be confined to its ability to interact with LAR.
KazrinE expression in epidermis and cultured keratinocytes
In order to analyse endogenous kazrinE expression, we generated a series of affinity-purified rabbit anti-peptide antibodies that detect the different kazrin isoforms (Fig. 1D) . We tested the specificity of the antibodies using lysates of 293T cells that had been transfected with HA-tagged kazrinA, HA-tagged kazrinE or the HA-tagged Cterminus of kazrinE containing the LHD and PDZ-binding motif (amino acids 408-775) ( Fig. 2A) .
Antiserum LS4 was generated against the C-terminal 20 amino acids common to kazrinA, kazrinB and kazrinC (Groot et al., 2004) . The peptide immunogen thus has only four amino acids in common with kazrinE. When HA immunoprecipitates from transfected 293T lysates were immunoblotted with LS4, a single band of approximately 50 kD, corresponding to kazrinA, was detected ( Fig.  2A) . By contrast, the LS7 antiserum, raised against a peptide common to all kazrin isoforms (Fig. 1D ), detected bands corresponding to both kazrinA and kazrinE ( Fig. 2A ). KazrinE had a mobility of approximately 105 kD, which is larger than the predicted molecular mass of 86 kD; this might reflect the conformation of the protein or post-translational modification, for example by phosphorylation. LS10, raised against a kazrinEspecific peptide (Fig. 1D) , detected full-length kazrinE and the kazrinE LHD, but not kazrinA ( Fig. 2A) .
When extracts of A431 cells, EJ/28 cells and human keratinocytes were immunoblotted with LS7, bands corresponding to kazrinA and kazrinB (50 kD), kazrinC (37 kD) and kazrinE (approximately 105 kD) were observed (Fig. 2B) . Endogenous kazrinE had the same mobility as HA-kazrinE (c.f. Fig. 2A,B ). In addition, we detected a higher-molecular-mass protein of approximately 150 kD (Fig. 2B) , which might correspond to complexes of the long and short forms of kazrin.
We previously observed that the abundance of the short kazrin isoforms increases as terminally differentiated cells accumulate during Ca 2+ -induced stratification of primary human epidermal keratinocytes in culture (Sevilla et al., 2008a) . To examine kazrinE expression, human keratinocytes grown under standard ('high calcium') conditions were harvested at 50, 80 or 100% confluence, or 3 days post-confluence (+3D) and immunoblotted with LS10. The abundance of kazrinE was reduced in post-confluent cultures (Fig. 2C) , suggesting either that its expression decreases during the later stages of terminal differentiation or that, like the short kazrin isoforms, it becomes incorporated into the cornified envelope (Groot et al., 2004) .
We next immunolabelled sections of human epidermis with antibodies to kazrinE and desmoplakin, a desmosome marker (Fig.  2D) . Desmoplakin staining was observed in all the living suprabasal layers of human interfollicular epidermis (Mils et al., 1992) . By contrast, kazrinE was expressed most highly in the basal to midspinous layers and decreased in the upper spinous layers (Fig. 2D) . KazrinE was expressed both at cell-cell borders, where it showed partial colocalisation with desmoplakin, and in the nucleus (Fig. 2D) .
The dual localisation of endogenous kazrinE at cell-cell borders and in nuclei was confirmed by immunostaining cultured primary human keratinocytes grown in standard 'high calcium' medium (Fig.  2E) . As in the epidermis, partial colocalisation of kazrinE and desmoplakin was observed (Fig. 2E) . In addition to the expected localisation of kazrinE in the nucleus and cell-cell borders, we also detected kazrinE in a filamentous network in the cytoplasm of some suprabasal cells that were undergoing terminal differentiation (Fig.  2F ).
KazrinE expression causes changes in keratinocyte shape and stimulates terminal differentiation
Overexpression of the short isoforms of kazrin causes profound changes in cell shape, reducing the amount of filamentous actin and decreasing Rho activity (Sevilla et al., 2008a) . In addition, overexpression of kazrinA stimulates keratinocyte terminal differentiation (Sevilla et al., 2008a) . To examine whether kazrinE had similar effects, primary human keratinocytes were transduced with a retroviral vector encoding HA-kazrinE or, as a control, GFP. Transduced cells were identified by GFP fluorescence or staining with an HA-specific antibody, and MetaMorph software was used to determine the perimeter and area of individual cells. As described previously (Sevilla et al., 2008a) , the shape of individual cells was scored as 'altered' if they exhibited loss of the normal cuboidal shape that is characteristic of basal keratinocytes. KazrinE induced a significant increase in cells with altered morphology; however, the effect was less pronounced than that of overexpressing kazrinA (Fig. 2G) .
The effect of kazrinE overexpression on terminal differentiation was measured using three parameters: increased forward and side scatter, expression of involucrin or expression of transglutaminase (Sevilla et al., 2008a) (Fig. 2H,I and data not shown). By each criterion, there was a significant increase in the proportion of terminally differentiated cells when keratinocytes transduced with HA-kazrinE were compared with cells transduced with GFP. Although the effect of kazrinE on cell shape was not as marked as that of kazrinA, the stimulation of terminal differentiation was equivalent (Fig. 2G-I and data not shown) (Sevilla et al., 2008a) .
Homo-and heterotypic interactions between kazrin protein isoforms
All kazrin isoforms contain a coiled-coil domain, which could potentially mediate association of the different isoforms with one another (Burkhard et al., 2001 ). In addition, liprin- protein family members are known to oligomerise via their coiled-coil domains (Serra-Pages et al., 1998) . To examine potential kazrin-kazrin interactions, we performed co-immunoprecipitations using lysates from Cos cells co-transfected with N-terminally HA-tagged kazrinA, B, C or E (H-A, H-B, H-C, H-E) and C-terminally FLAG-tagged kazrinA, B or C (A-F, B-F, C-F) (Fig. 3A) . Control cells were transfected with the HA-tagged construct together with pCIneo empty vector (V).
Proteins were immunoprecipitated with antibody against the FLAG-tag and immunoblotted with anti-HA or anti-FLAG (control for immunoprecipitation) antibodies (Fig. 3A) . The highermolecular-mass protein of approximately 150 kD observed in immunoblots of endogenous kazrin (Fig. 2B) was not evident in the co-immunoprecipitation experiments (Fig. 3A) . FLAG-tagged kazrinA, B or C were co-immunoprecipitated with HA-tagged kazrinA, B and C. FLAG-tagged kazrinA was coimmunoprecipitated with HA-tagged kazrinE. We conclude that all the kazrin isoforms are capable of interacting with one another.
Endogenous kazrinA, B and C are localized to desmosomes, the nucleus and cortical actin-based structures, but not to perinuclear filaments (Groot et al., 2004) . Because overexpressed kazrinE can accumulate in perinuclear filaments (Fig. 1G) , we predicted that overexpression of kazrinE would recruit endogenous kazrinA into perinuclear filaments. Overexpression of HA-tagged kazrinE did Journal of Cell Science 122 (22) not affect the endogenous level of kazrinA in keratinocytes, nor did HA-kazrinA overexpression affect endogenous kazrinE levels (Fig.  3B) . Nevertheless, HA-kazrinE recruited endogenous kazrinA into perinuclear filaments (Fig. 3C) , consistent with the ability of the two proteins to associate with one another (Fig. 3A) .
Accumulation of kazrinE in perinuclear filaments is mediated by the LHD
In order to identify the nature of the kazrinE filaments, we transiently transfected or stably retrovirally infected low-calcium cultures of human keratinocytes with N-terminally HA-tagged kazrinE (Fig. 3D,E) . To assess whether the C-terminus of kazrinE (LHD; containing the three putative SAM domains and the PDZbinding motif) was responsible for the filamentous distribution of kazrinE, we transiently transfected keratinocytes with an Nterminally HA-tagged LHD construct. The LHD had a similar distribution to full-length kazrinE and was detected in perinuclear filaments (Fig. 3D ). Because such filaments are not observed on overexpression of the short kazrin isoforms (Groot et al., 2004; Sevilla et al., 2008a) , we conclude that the LHD is both necessary and sufficient for accumulation of kazrinE in perinuclear filaments.
Whereas the kazrinE-containing filaments were predominantly perinuclear in cells cultured in low-calcium medium, 6 hours after transfer to standard 'high calcium' medium (1.8 mM Ca 2+ ) the filaments had become finer and showed reduced nuclear association (Fig. 3E) . Over time, the filaments elongated and extended through the cytoplasm towards the plasma membrane (Fig. 3E) . The kinetics of the change in subcellular distribution were significantly slower than the kinetics of Ca 2+ -induced desmosome assembly and accumulation of the short kazrin isoforms in desmosomes (Groot et al., 2004; Sevilla et al., 2008a) .
KazrinE associates with stabilised microtubules
KazrinE filaments did not colocalise with F-actin, keratins or with the majority of cytoplasmic microtubules (Fig. 4A) . However, they did show complete colocalisation with stabilised, acetylated microtubules, both in untreated and nocodazole-treated cells (Fig.  4B and data not shown) . In immunoblots, the total level of acetylated tubulin was the same in control cells and in cells retrovirally transduced with HA-tagged kazrinE (data not shown).
The microtubule cytoskeleton undergoes major reorganisation during keratinocyte terminal differentiation, coincident with a reduction in filamentous actin (Lewis et al., 1987; Lechler and Fuchs, 2007) (Fig. 4C-F) . Whereas, in basal keratinocytes, microtubules are centrosome-associated ( Fig. 4A; Fig. 4C , arrowheads), in differentiating, suprabasal cells the microtubules are organised into thick mats and distinctive coils (Fig. 4C, asterisks ; (Lewis et al., 1987; Lechler and Fuchs, 2007) . The association of endogenous kazrinE with microtubules was observed in the uppermost layers of differentiating keratinocytes in culture ( Fig. 4D,F ; see also Fig. 2F ). There was no colocalisation of periplakin with microtubules in differentiated cells (Fig. 4C,E) . KazrinE was mainly desmosomal in the lower suprabasal layers, but in the more differentiated layers the microtubule association was evident (Fig. 4D,F) . The colocalisation of endogenous kazrinE with microtubules was less pronounced than that of overexpressed kazrinE, which might explain why an association of the short kazrin isoforms with microtubules has yet to be observed (Groot et al., 2004 ) (data not shown).
We conclude that, in addition to its association with desmosomes and the nucleus, endogenous kazrinE can associate with microtubules. The microtubule association is mediated by the LHD and is a specific feature of differentiating cells. Our observations add to the emerging concept that the microtubule cytoskeleton contributes to the regulation of epidermal cell adhesion and cornified envelope assembly. Microtubule disruption in human keratinocytes can promote the assembly of adherens junctions (Kee and Steinert, 2001; Kee et al., 2002) and incorporation of S100A11 into the cornified envelope is thought to depend on microtubules (Broome and Eckert, 2004) . Conversely, desmoplakin is required for differentiation-specific reorganisation of epidermal microtubules, and acts by recruiting ninein from centrosomes to desmosomes (Lechler and Fuchs, 2007) . Our studies identify kazrinE as a novel interactor with desmosomes and microtubules, and suggest a potential role in coordinating the onset of differentiation with changes in keratinocyte adhesion and the cytoskeleton.
Materials and Methods

Sequence analysis
The BLAST 2.0 (NCBI, Bethesda, MD) and BLAT (Golden Path Genome Browser, Santa Cruz, CA) programs were used to search human and mouse EST databases and genome sequences. ClustalX software (Larkin et al., 2007) was used to generate the phylogenetic tree in Fig. 1B .
DNA clones and constructs
The eGFP-LAR construct was kindly provided by Wiljan Hendriks (Nijmegen Centre for Molecular Life Sciences, The Netherlands). N-terminally HA-tagged kazrinA, kazrinB and kazrinC in EFplinkHA were described previously (Groot et al., 2004) . C-terminally FLAG-tagged kazrin isoforms were generated using the forward primers 5Ј-GCGGAATTCGCCACCATGATGGAAGACAATAAGCAG-3Ј (kazrinA), 5Ј-CGGGAATTCGCCACCATGCGGGCGGCCGACTCGGG-3Ј (kazrinB) and 5Ј-GGCGAATTCGCCACCATGAAGGAGATGTTGGCGAAG-3Ј (kazrinC), in combination with reverse primer 5Ј-GCGGTCGACTCACTTATCG TCGTCAT -CCTTGTAATCTCCTCCTCCCCAGTCCGCGTCCTCCTCTAT-3Ј. PCR products were digested with EcoRI and SalI, and ligated into pCIneo (Invitrogen).
IMAGE clones encoding mouse kazrinA (no. 3667377) and human kazrinE (no. 5242289) in pCMV-Sport6 were obtained from the MRC UK HGMP Resource Centre and confirmed by sequencing. pCIneo HA-kazrinE was generated by PCR amplifying kazrinE using primers 5Ј-ATGATGGAAGACAATAAGCAG-3Ј (forward) and 5Ј-GCGTCTAGACACGTTGGTGACCTCCAGGCT-3Ј (reverse), then digesting with AgeI and XbaI and ligating into similarly digested pCIneo HA-kazrinA (Sevilla et al., 2008a) . pBABEpuro HA-kazrinE was generated by cloning the AgeI-SalI fragment from pCIneo HA-kazrinE into similarly digested pBABEpuro HA-kazrinA (Sevilla et al., 2008a) .
The C-terminus of kazrinE (nucleotides 1222-2326) was amplified using primers 5Ј-GCGCTCGAGGCCACCATGTACCCCTACGACGTGCCCGACTATGCCGGA -GGAGGAGACTCGGACAGCCAGTGCA-3Ј (forward) and 5Ј-GCGTCTAGA -TTACACGTTGGTGACCTCCA-3Ј (reverse), digested with XhoI and XbaI, and ligated into pBluescript. The XhoI-NotI fragment of pBluescript HA-kazrinE-LHD was cloned into pCIneo.
Cell culture
Primary human keratinocytes (strains kv and kt, passages 2-4) and mouse keratinocyte lines were cultured, transiently transfected and/or retrovirally infected as previously described (DiColandrea et al., 2000; Groot et al., 2004; Sevilla et al., 2008a) . A431, Cos-7, EJ/28 and 293T cells were maintained in DMEM with 10% FCS. Transient transfection of Cos-7, A431 and 293T cells was performed using Superfect (Qiagen), Lipofectamine (Invitrogen) and FuGENE 6 Transfection Reagent (Roche), respectively.
Where indicated, cells were treated with 33 M nocodazole (Sigma-Aldrich) or 50 ng/ml recombinant human EGF (Peprotech).
RT-PCR
RNA was prepared using TriReagent (Molecular Research Center). The SuperScript One-Step RT-PCR with Platinum Taq kit (Invitrogen) was used for semi-quantitative RT-PCR. Total kazrin mRNA (all isoforms) was amplified using a forward primer in exon 7 (5Ј-GGCGACAGTCCCGGCCCAGTTCAGAAG-3Ј) and a reverse primer in exon 8 before the kazrinE splice site (5Ј-CCCTCTGGCGAAGACG - CGGGAGATGGA-3Ј). To selectively amplify the short isoforms, the forward primer was used in combination with a reverse primer after the kazrinE splice site in exon 8 (5Ј-CACCAGTCCGCGTCCTCCTCTATGTAAT-3Ј). To selectively amplify kazrinE, the forward primer was combined with a reverse primer in exon 9 (5Ј-CCAGCTCCACCTGCTGCAGCCGGTCCAT-3Ј). All PCR products were confirmed by sequencing. Primers specific for human GAPDH mRNA were used to control for input mRNA levels (Groot et al., 2004) .
Antibodies
Mouse monoclonal antibodies were used at the dilutions stated: HA.11 (1:1000; anti-HA, Covance Research Products), M2 (1:1000; anti-FLAG, Sigma Aldrich), AC40 (1:500; anti-actin, Sigma-Aldrich), LP34 (1:100; specific for keratin filaments) (Lane et al., 1985) , clone 2-28-33 (1:1000; anti-b-tubulin, Sigma-Aldrich), clone 6-11B-1 (1:1000; anti-acetylated-tubulin, Sigma-Aldrich), SY5 (1:100; anti-human involucrin), BC.1 (1:100; anti-transglutaminase-1, a gift from Robert Rice, University of California, CA), p-Tyr-100 (1:1000; anti-phosphotyrosine, Cell Signaling) and T6199 (1:2500; anti--tubulin, Sigma-Aldrich). The following rabbit antisera were also used: Y11 (1:50; anti-HA, Santa Cruz Biotechnology), anti-FLAG (1:100; Sigma-Aldrich), LS4 (1:100; anti-kazrin) (Groot et al., 2004) and LS7 (1:500; anti-kazrin) (Sevilla et al., 2008a) . For flow cytometry, SY5 and BC.1 were directly conjugated to Alexa Fluor 633 using the Protein Labeling kit from Invitrogen. HA.11 coupled to Alexa Fluor 488 was purchased from Covance Research Products.
Amino acids 1646-1693 of human periplakin (KREQRENHLRRSIVVIHPD -TGRELSPEEAHRAGLIDWNMFVKLRSQEC) were used to generate the TD2 rabbit antiserum (Määttä et al., 2001 ). Amino acids 733-750 (SKDPDFHDDYGSLQNEDC) of human kazrinE were used to generate LS10. Anti-kazrin antibodies were affinity purified on columns containing their respective immunogens coupled to Amino-Link Coupling Gel (Perbio).
Secondary antibodies were Alexa-Fluor-488-or -594-conjugated donkey anti-rabbit or mouse IgG and rabbit anti-goat IgG (Invitrogen; diluted 1:1000), or HRP-conjugated donkey anti-rabbit or anti-mouse IgG (Amersham Biosciences; diluted 1:4000).
Immunofluorescence staining and microscopy
Immunofluorescence labelling was performed as described previously (DiColandrea et al., 2000) . Samples were examined using a Leica Tandem SP5 laser scanning confocal microscope equipped with 405 nm, 488 nm and 594 nm lasers and immersion lenses HC PL APO 20ϫ 0.7 IMM, HCX PL APO 40ϫ 1.25 Oil and HCX PL APO 63ϫ 1.4 Oil (Leica, Heidelberg, Germany). Three-dimensional reconstructions of zstacks were made using the Leica Application Suite software. Digital images were prepared using Adobe Photoshop CS2 software and compiled using Adobe Illustrator CS2.
Immunoprecipitation and immunoblotting
Cos-7 cells were lysed with ice-cold buffer (0.15 M NaCl, 0.05 M Tris, 5 mM EDTA, 0.5% NP-40) containing protease inhibitors (Roche). A431 cells transfected with pCINeo-HA-kazrinE or pEGFP-C2, and 293T cells were lysed with ice-cold buffer (0.15 M NaCl, 0.05 M Tris, 5 mM EDTA, 0.02% NP-40) in the presence of protease inhibitors (Roche) and in the presence or absence of phosphatase inhibitors as indicated (PhosphoSTOP tablets, Roche; or 100 mM NaF, 2 mM Na 3 VO 4 , 20 mM Na 4 P 2 O 7 ). Insoluble material was sedimented by centrifugation for 10 minutes at 4°C at high speed in a microcentrifuge. Immunoprecipitation and immunoblotting were performed as previously described (Groot et al., 2004; Sevilla et al., 2008a) .
Flow cytometry
Intracellular staining of keratinocytes for involucrin and transglutaminase 1 was performed essentially as described previously (Sevilla et al., 2008a) . Flow cytometry was performed with the BD FACSCalibur System (BD Biosciences) using BD CellQuest software. FlowJo software (Tree Star) was used to further analyse the flowcytometry data.
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Note added in proof
A further kazrin isoform, kazrinF, has recently been reported (Wang et al., 2009 ).
